Health Condition 1: H10- Conjunctivitis
Conditions
Interventions
None listed
Sponsors
Central Council for Research in Ayurvedic Sciences (C.C.R.A.S)
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects of age 18-40 years 2.Subjects presenting with signs and symptoms of chronic allergic conjunctivitis 3.Subjects who agree to participate in the study and submit a written informed consent form 4.Willing and able to participate for 1 week
Exclusion criteria
Exclusion criteria: 1.Participants having any complications with corneal involvement, conjunctivitis other than allergic, positive for conjunctival smear and culture, 2.disease of lachrymal system,genetic predisposition to allergy,concurrent co-morbid serious hepatic disorder, renal disorders, severe pulmonary dysfunction, 3.uncontrolled diabetes mellitus or poorly controlled hypertension 4.Uncontrolled diabetes mellitus and Uncontrolled hypertension 5.Subjects with concurrent Hepatic Dysfunction or Renal Dysfunction,uncontrolled Pulmonary Dysfunction. 6.pregnant or lactating females 7.patients on steroids, oral contraceptive pills, estrogen replacement therapy 8.smokers,alcoholics,drug abusers 9.patients on long-term drug treatment as in rheumatoid arthritis, psycho-neuro-endocrinal disorders 10.hypersensitivity to any of the ingredients of the trial drug 11.patients who have undergone any clinical trial during past 6 months were excluded from the study. 12.Any other condition which the Investigator thinks may jeopardize the study. 13.Subjects who refuse to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The feasibility and acceptability of the standardized procedures of Seka and Aschyotana will be assessed by the procedure completion rate (proportion of participants who successfully complete the procedures as per protocol), protocol adherence rate (compliance with procedural steps and post-procedure care), and tolerability of the procedures, evaluated in terms of participant comfort, occurrence of adverse events, and overall acceptance from baseline to the end of the intervention period.Timepoint: Baseline and at the end of the study 6th day | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The symptomatic improvement in Itching, lacrimation, photophobia, foreign body sensation, burning sensation, lid swelling assessed by VAS (0 100 scale) and redness assessed by grading of scores at every visit .Timepoint: Baseline and at the end of the study 6th day | — |
Countries
India
Contacts
Public ContactDr Kamble Pallavi Namdev
Regional Ayurveda Research Institute Lucknow
Outcome results
None listed